2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
S Yokota
◽
T Imagawa
◽
T Miyamae
◽
K Kasai
◽
M Mori
◽
...
2013 ◽
Vol 65
(9)
◽
pp. 2486-2496
◽
Daniel J. Lovell
◽
Edward H. Giannini
◽
Andreas O. Reiff
◽
Yukiko Kimura
◽
Suzanne Li
◽
...
S Yokota
◽
T Nozawa
◽
T Kanetaka
◽
K Yamazaki
◽
T Sato
◽
...
2010 ◽
Vol 62
(6)
◽
pp. 1792-1802
◽
Nicolino Ruperto
◽
Daniel J. Lovell
◽
Pierre Quartier
◽
Eliana Paz
◽
Nadina Rubio-Pérez
◽
...
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 401.2-402
◽
N. Ruperto
◽
H.I. Brunner
◽
P. Quartier
◽
T. Constantin
◽
E. Alexeeva
◽
...
N Ruperto
◽
◽
P Quartier
◽
N Wulffraat
◽
P Woo
◽
...
2013 ◽
Vol 71
(Suppl 3)
◽
pp. 704.13-704
M. Trachana
◽
P. Pratsidou-Gertsi
◽
O. Vougiouka
G Horneff
◽
I Huppertz
◽
P Haas
◽
K Minden
◽
G Ganser
◽
...
2012 ◽
Vol 64
(2)
◽
pp. 557-567
◽
Nicolino Ruperto
◽
Pierre Quartier
◽
Nico Wulffraat
◽
Patricia Woo
◽
Angelo Ravelli
◽
...
2015 ◽
Vol 33
(33)
◽
pp. 4056-4059
◽